Leveraging GWAS data derived from a large cooperative group trial to assess the risk of taxane-induced peripheral neuropathy (TIPN) in patients being treated for breast cancer: Part 2—functional implications of a SNP cluster associated with TIPN risk in patients being treated for breast cancer

1. Lustberg, M.
2. Wu, X.
3. Fernández-Martínez, J.L.
4. de Andrés-Galiana, E.J.
5. Philips, S.
6. Leibowitz, J.
7. Schneider, B.
8. Sonis, S.